Each month, we like to feature one of our attorneys to help you get to know our team better. We sat down with one of our Houston attorneys, Mark Linder, to talk about his background in the legal field and what he is currently working on. Continue reading “Attorney Spotlight – Mark Linder”
Mark Lanier and the Business Litigation team of The Lanier Law Firm has been retained as trial counsel by the State of Texas in antitrust litigation against Google. The 130-page lawsuit, filed on December 16 in the United States District Court for the Eastern District of Texas and joined by nine other state attorneys general, alleges the tech giant engages in anticompetitive practices in dominating the online display advertising market.
“This is a textbook example of an antitrust case. This is why the laws exist,” Mr. Lanier says in an interview with Texas Lawyer. “Google is—in fact, several of the tech companies now—in my mind are equivalent to the oil barons who brought forth the antitrust laws.” Continue reading “The Lanier Law Firm’s Going After Google”
What they’re reporting about the court’s decision:
Kevin Parker, a lawyer for the plaintiffs, said in a statement: “Johnson & Johnson should accept the findings of the jury and the appellate court and move forward with proper compensation to the victims.”
Each month, we like to feature one of our attorneys to help you get to know our team better. We sat down with one of our Houston attorneys, Benjamin Pyle, to talk about his background in the legal field and what he is currently working on. Continue reading “Attorney Spotlight – Benjamin Pyle”
The Supreme Court of the State of Missouri has denied an effort by Johnson & Johnson’s legal counsel to seek reconsideration of a state appellate court’s recent opinion that upheld $2.11 billion in punitive and compensatory damages against the company and its affiliate in findings that the company’s asbestos-contaminated, talc-based baby powder caused the ovarian cancer of 20 plaintiffs. Continue reading “Missouri Supreme Court Denies Review of $2.11 Billion Talc-Ovarian Cancer Ruling”